<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28967/metastatic-rcc-metastasectomy-study-procedure-does-not-prolong-survival-trend-towards-worse-os-no-benefit-to-relapse-free-survival-at-3-years?channelName=AnnualCancerMeeting&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Metastatic RCC Metastasectomy Study: Procedure Does Not P...

Name: Metastatic RCC Metastasectomy Study: Procedure Does Not P...
Uploaded: 2019-06-05T08:22:39
Duration: 1 min 42 s
Description: Elizabeth R. Plimack MD MS @ERPlimackMD Of The Fox Chase Cancer Center Discusses Metastatic RCC Metastasectomy Study: Procedure Does Not Prolong Survival, Trend Towards Worse OS, No Benefit To Relapse Free Survival At 3 Years.

Metastatic RCC Metastasectomy Study: Procedure Does Not Prolong Survival, Trend Towards Worse OS, No Benefit To Relapse Free Survival At 3 Years

00:01:42

Annual Meeting

3 years 84 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28967/metastatic-rcc-metastasectomy-study-procedure-does-not-prolong-survival-trend-towards-worse-os-no-benefit-to-relapse-free-survival-at-3-years?channelName=AnnualCancerMeeting&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/28967/metastatic-rcc-metastasectomy-study-procedure-does-not-prolong-survival-trend-towards-worse-os-no-benefit-to-relapse-free-survival-at-3-years?channelName=AnnualCancerMeeting&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/28967/metastatic-rcc-metastasectomy-study-procedure-does-not-prolong-survival-trend-towards-worse-os-no-benefit-to-relapse-free-survival-at-3-years?channelName=AnnualCancerMeeting&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/28967?channelName=AnnualCancerMeeting"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190605202239_7521/video_190605202239_7521.jpg?cache=15669162411678829655">Metastatic RCC Metastasectomy Study: Procedure Does Not Prolong Survival, Trend Towards Worse OS, No Benefit To Relapse Free Survival At 3 Years</a>

Link (BBCode):

[url=https://oncologytube.com/v/28967?channelName=AnnualCancerMeeting][img]https://oncologytubecom.cdn.ypt.me/videos/video_190605202239_7521/video_190605202239_7521.jpg?cache=15669162411678829655[/img]Metastatic RCC Metastasectomy Study: Procedure Does Not Prolong Survival, Trend Towards Worse OS, No Benefit To Relapse Free Survival At 3 Years[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Kidney

Description:

Elizabeth R. Plimack MD MS @ERPlimackMD Of The Fox Chase Cancer Center Discusses Metastatic RCC Metastasectomy Study: Procedure Does Not Prolong Survival, Trend Towards Worse OS, No Benefit To Relapse Free Survival At 3 Years.